The Fresenius Kabi Pharmaceuticals Holding, Inc. Board of Directors established an audit committee with chartered responsibilities immediately upon the merger with Fresenius in September 2008.  The audit committee is specifically chartered to oversee the accounting and financial reporting processes of FKP Holdings and its subsidiaries and the audits of the financial statements pursuant to requirements of the NASDAQ Stock Market and any other requirements as deemed appropriate.  The current charter of the audit committee provides a more specific outline of the audit committee's scope and responsibilities.